Literature DB >> 34861871

Correction to: ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.

Weipu Mao1,2,3, Keyi Wang4, Bin Xu5,6, Hui Zhang7, Si Sun1, Qiang Hu1, Lei Zhang1, Chunhui Liu1, Shuqiu Chen1, Jianping Wu1, Ming Chen8,9,10, Wei Li11, Bo Peng12.   

Abstract

Entities:  

Year:  2021        PMID： 34861871      PMCID： PMC8697437          DOI： 10.1186/s12943-021-01459-8

Source DB:  PubMed          Journal:  Mol Cancer        ISSN： 1476-4598            Impact factor:   27.401


× No keyword cloud information.
Correction to: 20, 142 (2021). https://doi.org/10.1186/s12943-021-01443-2 Following the publication of the original article [1], the authors found out that the Additional file 1 is outdated. Updated version is contained on this article, see Additional file section. The original article has been corrected. Additional file 1.
  1 in total

1.  ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.

Authors:  Weipu Mao; Keyi Wang; Bin Xu; Hui Zhang; Si Sun; Qiang Hu; Lei Zhang; Chunhui Liu; Shuqiu Chen; Jianping Wu; Ming Chen; Wei Li; Bo Peng
Journal:  Mol Cancer       Date:  2021-11-05       Impact factor: 27.401
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.